Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB 40101 (Alliance)
- Citation:
- J Clin Oncol vol 32 (22) 2311-2317
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 3
- Parents:
- 944
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10 CA047577, U10 CA032291, CA33601, P30 CA016672, U10 CA077658, CA47577, CA32291, N01 CA032102, U10 CA021115, U10 CA031946, CA3360, CA77651, U10 CA033601, U10 CA180821, U10 CA045418, U10 CA032102, U10 CA047559, U10 CA077651, P30 CA015083, U10 CA180882, CA47559, CA45418, U10 CA180820, CA25224, CA77658, U10 CA180867, U10 CA180838, CA21115, U10 CA025224, U10 CA180888, CA31946
- Corr. Author:
- Authors:
- Lawrence N. Shulman Donald A. Berry Constance T. Cirrincione Heather P. Becker Edith A. Perez Ruth O'Regan Silvana Martino Charles L. Shapiro Charles J. Schneider Gretchen Kimmick Harold J. Burstein Larry Norton Hyman Muss Clifford A. Hudis Eric P. Winer
- Networks:
- Study
- CALGB-40101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Bc5, ORIGINAL REPORTS, Breast Cancer